FCMAX
Price
$12.36
Change
-$0.00 (-0.00%)
Updated
Jun 12 closing price
Net Assets
1.87B
FCTFX
Price
$12.35
Change
-$0.00 (-0.00%)
Updated
Jun 12 closing price
Net Assets
1.87B
Interact to see
Advertisement

FCMAX vs FCTFX

Header iconFCMAX vs FCTFX Comparison
Open Charts FCMAX vs FCTFXBanner chart's image
FCMAX vs FCTFX Comparison Chart in %
View a ticker or compare two or three
VS
FCMAX vs. FCTFX commentary
Jun 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FCMAX is a Hold and FCTFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FCMAX (1.87B) and FCTFX (1.87B) have equal amount of cash in the bank . FCTFX pays higher dividends than FCMAX: FCTFX (3.03) vs FCMAX (2.70). FCMAX was incepted earlier than FCTFX: FCMAX (24 years) vs FCTFX (42 years). FCMAX (0.76) is less costly to investors than FCTFX (0.43). FCMAX (19.00) and FCTFX (19.00) have comparable annual turnover. FCMAX (0) and FCTFX (0) have matching initial minimum investment requirements. FCTFX annual gain was more profitable for investors over the last year : 6.91 vs. FCMAX (6.56). FCTFX return over 5 years is better than : 4.78 vs. FCMAX (2.99).
FCMAXFCTFXFCMAX / FCTFX
Total Expense Ratio0.760.43177%
Annual Report Gross Expense Ratio0.760.43177%
Fund Existence24 years42 years-
Gain YTD0.9621.18381%
Front Load4%N/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.87B1.87B100%
Annual Yield % from dividends2.703.0389%
Returns for 1 year6.566.9195%
Returns for 3 years11.6612.7891%
Returns for 5 years2.994.7862%
Returns for 10 years17.0021.0781%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IDR36.391.88
+5.45%
Idaho Strategic Resources
BR144.870.99
+0.68%
Broadridge Financial Solutions
GLMD0.61N/A
-0.63%
Galmed Pharmaceuticals Ltd
FSLY18.55-0.33
-1.75%
Fastly
ONCY0.80-0.02
-2.07%
Oncolytics Biotech